Clinical Trials Browser

Phase 2 × CRC × 90 days × Clear all

NCT07511972 2026-04-06

Study of NGM707 in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies

Phase 2 Withdrawn

CRC

NCT07381309 2026-02-02

VVSHIP

Phase 2 Not yet recruiting

Gastrointestinal

CRC